MKS INC.

MKSI

CIK 0001049502 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.03B
↑+10.6% +$99Mvs FY2024 (Q4)
Operating Income
$143M
↑+5.1% +$7Mvs FY2024 (Q4)
Net Income
$89M
↑+11.3% +$9Mvs FY2024 (Q4)
Gross Profit
$479M
↑+8.6% +$38Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
42/100
  • Profitability
    12ROIC 7.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.71 (above 1.5 = solid)
  • Leverage
    24D/E 1.53 (under 0.5 = conservative)
  • Efficiency
    19Asset Turnover 0.45x (1.0+ = capital-efficient)
  • Growth
    52Revenue YoY +10.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    42Op Margin 13.8% · trend -0.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project MKSI's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

11%

Trailing 3-yr CAGR was 10.8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$142.69
Total enterprise IV
$9.66B
Diluted shares
0.07B
Terminal PV
$7.11B (74% of total)
Year-5 FCF
$837M
YearProjected FCFDiscounted PV
+1$552M$502M
+2$612M$506M
+3$680M$511M
+4$754M$515M
+5$837M$520M
Terminal$11.45B$7.11B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$148M
investment in PP&E
Dividends paid (TTM)
$59M
cash returned to holders
Stock buybacks (TTM)
$45M
share count reduction
Stock-based comp (TTM)
$55M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.80B
everything owned
Total liabilities
$6.08B
everything owed
Stockholders' equity
$2.72B
shareholder claim
Net debt
$3.73B
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+10.6% +$99M
$1.03B
Net Income↑+17.6% +$16M
$107M
Free Cash Flow↓-26.4% -$33M
$92M
Operating Margin↓-0.7pts
13.8%

Drill down